Panacea Life Sciences Holdings, Inc. Notes Reduction
Panacea Life Sciences Holdings, Inc. (PLSH) reported Notes Reduction of $12.72 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2023-03-30
- Panacea Life Sciences Holdings, Inc. notes reduction for the quarter ending 2021-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. notes reduction for the quarter ending 2021-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. notes reduction for fiscal 2021 was $12.72M.
| Period end | Notes Reduction 3 month | Notes Reduction 6 month | Notes Reduction 9 month | Notes Reduction 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $12.72M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $12.72M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $12.72M 10-Q · filed 2022-08-15 |